When was Neuralink founded?

Neuralink was founded in 2016 and became a unicorn in 2021, reaching the milestone in 5 years. It raised its 1st funding round 1 year after its incorporation.

Where is Neuralink located?

Neuralink is headquartered in Fremont, United States. It is registered at Fremont, California.

How many employees does Neuralink have?

As of Apr 30, 2026, the latest employee count at Neuralink is 659.

Is Neuralink a funded company?

Neuralink is a funded company, having raised a total of $1.29B across 7 funding rounds to date. The company's 1st funding round was a $27M Series B round, raised on Aug 15, 2017.

How much is Neuralink worth?

The latest valuation of Neuralink is $9B as of May 27, 2025.

When was the latest funding round of Neuralink?

Neuralink's latest funding was a Series E round on May 08, 2026, with participation from 1 investor.

Is Neuralink a Neurology company?

The primary sectors of Neuralink are Neurology and Brain Computer Interface.

Where does Neuralink rank among its competitors?

Neuralink ranks 2nd amongst 100 active competitors, of which 29 are funded. It stands 1st in terms of total funding among its competitors.

Who are the top competitors of Neuralink?

Neuralink's top competitors include BIOS, Openwater and BrainScope. Among them, Neuralink secured the most recent funding round in May, 2026.

Neuralink - 2026 Company Profile, Team, Funding & Competitors

Neuralink is a series E company based in Fremont (United States), founded in 2016 by Elon Musk. It operates as a Provider of implantable brain-computer interfaces. Neuralink has raised $1.29B in funding from Founders Fund and Vy Capital, with a current valuation of $9B. The company has 100 active competitors, including 29 funded and 13 that have exited. Its top competitors include companies like BIOS, Openwater and BrainScope.

Sectors and market segments that Neuralink operate in

Neuralink serves in the Life Sciences, High Tech market segments.The primary business model of Neuralink are:

Company Details

Provider of implantable brain-computer interfaces. It offers flagship product the N1 Implant the Link which is a coin-sized device designed to decode neural signals and enable users to control digital devices using only their thoughts. It also has an experimental device called Blindsight to restore vision in individuals with optic nerve damage by directly stimulating the visual cortex.

Website: neuralink.com
Social
Email ID: *****@neuralink.com
Registered Address: Fremont, California

Key Metrics

Founded Year

2016

Location

Fremont, United States

Stage

Series E

Total Funding

$1.29B in 7 rounds

Latest Funding Round

Series E, May 08, 2026, Undisclosed

Post Money Valuation

$9B as on May 27, 2025

Investors

Founders Fund & 26 more

Ranked

2^nd among 100 active competitors

Employee Count

659 as on Apr 30, 2026

Similar Companies

BIOS & 117 more

View Neuralink's full profile

Neuralink is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NEURALINK CORP CIN: 813312960 , United States, Active	Dec 31, 1999	-	309 (As on Dec 31, 2024)	-
Neuralink Corp. CIN: 32077682303 , United States, Active	Feb 02, 2021	-	-	-

Neuralink has raised a total funding of $1.29B over 7 rounds. Its first funding round was on Aug 15, 2017. Its latest funding round was a Series E round on May 08, 2026 for an undisclosed amount. 1 investor participated in its latest round. Neuralink has 23 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Neuralink:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 08, 2026	Undisclosed	Series E	-	-	-	Oman Investment Authority
May 27, 2025	$650M	Series E	$9B	-	-	Founders Fund, Google Ventures, Sequoia Capital, Lightspeed Venture Partners, Thrive Capital, ARK Investment Management
Nov 25, 2023	$43M	Series D	$5B	-	Founders Fund	-

Access funding benchmarks and valuations. Sign up today!

View details of Neuralink's funding rounds and investors

The founders of Neuralink is Elon Musk. Elon Musk is the CEO of Neuralink.

Here are the details of Neuralink's key team members:

Elon Musk: Owner of Neuralink.
Jared Birchall: CEO of Neuralink.
Contact Info: 1 email address

View details of Neuralink's Founder profiles and Board Members

Neuralink's employee count trend

Neuralink has 659 employees as of Apr 26. Here is Neuralink's employee count trend over the years:

Uncover Neuralink's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neuralink include BIOS, Openwater and BrainScope. Here is the list of Top 10 competitors of Neuralink, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BIOS 2015, Cambridge (United Kingdom), Series A	Provider of AI-based platforms to diagnose nervous system disorders	$26M	Cisco Investments, AME Cloud Ventures & 18 others	59/100
2nd	Neuralink 2016, Fremont (United States), Series E	Provider of implantable brain-computer interfaces	$1.29B	Sequoia Capital, Google Ventures & 25 others	67/100
3rd	Openwater 2016, San Francisco (United States), Series C	Provider of imaging technologies for medical diagnosis and treatments	$100M	Excel Venture Management, Lauder Partners ... & 9 others	55/100
4th	BrainScope 2006, Bethesda (United States), Series B	Developer of non-invasive point-of-care diagnostic device for EEG recording and diagnosing traumatic brain injury	$62.2M	General Electric, Defense.gov & 11 others	53/100
5th	Kernel 2016, Los Angeles (United States), Series C	Developer of multimodal brain measurement technology for neuromedicine	$158M	Khosla Ventures, General Catalyst & 3 others	52/100
6th	Paradromics 2015, Austin (United States), Series A	Provider of data streaming brain-computer interfaces	$88.7M	DARPA, Stelac & 26 others	52/100
7th	Axoft 2021, Cambridge (United States), Seed	Offers development and implementation services for NUI sector	$17.3M	Reform Ventures, Alumni Ventures & 11 others	46/100
8th	Sense Neuro Diagnostics 2013, Cincinnati (United States), Seed	Non-invasive brain activity monitoring device	$4.64M	Defense.gov, Global Cardiovascular Innovation Center ... & 3 others	43/100
9th	Evoke Neuroscience 2009, New York City (United States), Acquired	Developer of memory loss biomarkers to treat cognitive disorders	-	Octane	41/100
10th	NeuroOne 2023, Eden Prairie (United States), Public	Developer of minimally invasive thin film electrodes for the diagnosis of neurological conditions	-	-	40/100